XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.880
+0.130 (7.43%)
Nov 22, 2024, 4:00 PM EST - Market closed
XTL Biopharmaceuticals Employees
As of December 31, 2016, XTL Biopharmaceuticals had 7 total employees, including 2 full-time and 5 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$54,000
Market Cap
21.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 7 | 1 | 16.67% |
| Dec 31, 2015 | 6 | 1 | 20.00% |
| Dec 31, 2014 | 5 | -7 | -58.33% |
| Dec 31, 2013 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 100 |
| Enlivex Therapeutics | 71 |
| Inspira Technologies Oxy B.H.N. | 42 |
| IN8bio | 31 |
| Pulmatrix | 22 |
| NeuroSense Therapeutics | 18 |
| iBio, Inc. | 16 |
| NeuroOne Medical Technologies | 16 |
XTLB News
- 3 months ago - XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million - GlobeNewsWire
- 6 months ago - XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewsWire
- 8 months ago - XTL To Aquire The Social Proxy - GlobeNewsWire
- 1 year ago - XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel - GlobeNewsWire
- 1 year ago - XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 3 years ago - Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting - PRNewsWire